17 electronic-"https:"-"https:"-"https:"-"https:"-"https:"-"UCL" Fellowship positions at University of Birmingham
Sort by
Refine Your Search
-
( [email protected] ) To download the full job description and details of this position and submit an electronic application online please click on the Apply button. Please see MOBILITY website for
-
will work on “bcc-superalloys” ( https://doi.org/10.1016/j.scriptamat.2025.116761 ) to achieve top scientific outputs (e.g. Ti https://doi.org/10.1016/j.scriptamat.2017.06.038 , W https://doi.org
-
all of these can be found on the MOBILITY website ( https://www.birmingham.ac.uk/about/college-of-medicine-and-health/research-office/fellowship-academy-for-medicine-and-health/mobility ). Please also
-
Type 1 diabetes For disease Interception) ( https://www.edent1fi.eu ). The research fellow is sought to support the UK component which is linked to the existing T1D screening program scaled up
-
national rollout. Working closely with the Chief Investigator, Prof. James Kirkbride (UCL), and Deputy Chief Investigators, Prof. Rachel Upthegrove (Oxford) and Dr. Lowri Griffiths (Birmingham), the
-
Background A Bone Cancer Research Trust/GOSH funded Research Fellow post, starting January 2027 within the lab of Prof. Clare Davies (https://www.claredavieslab.org/) and Dr. Susanne Gatz at the
-
the question of ‘When has remission been achieved?’: https://www.birmingham.ac.uk/news/2025/birmingham-joins-world-leading-researchers-for-study-helping-arthritis-patients-live-drug-free. This
-
0.5 FTE. Find out more about the College of Medicine and Health our Department by visiting the links below: https://www.birmingham.ac.uk/about/college-of-medicine-and-health Department of Applied Health
-
tested within a feasibility study ( https://www.journalslibrary.nihr.ac.uk/hta/MWTQ5721 ). The trial is led by Professor Peter Langdon together with the Cardiff Centre for Trials Research (CTR). Role
-
tested within a feasibility study ( https://www.journalslibrary.nihr.ac.uk/hta/MWTQ5721 ). The trial is led by Professor Peter Langdon together with the Cardiff Centre for Trials Research (CTR). Role